Clinical Trial Update: 5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the combination of 5-Fluoro-2'-Deoxcytidine and tetrahydrouridine in patients with advanced cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 5-Fluoro-2'-Deoxcytidine (5-fluorodeoxycytidine)
• Tetrahydrouridine (tetrahydrouridine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Neoplasms | Phase 1 | Status: COMPLETED